This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Transdermal Effects of a Synthetic -Melantropin/Corticotropin6-9 Analog in Multiple Sclerosis

Wolfgang R. Kiessling, MD
Clinic for Multiple Sclerosis and Amyotropic Lateral Sclerosis Center for Neurological Study and Treatment 7292 Schönmünzach, West Germany

Arch Neurol. 1987;44(10):995.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The use of corticotropin is well accepted in the symptomatic treatment of multiple sclerosis (MS). As far as we know, however, the effects of corticotropin fragments have never been investigated in MS. We, therefore, tested the clinical response of a transdermal therapeutic system (TTS) with the tetrapeptide histidine-phenylalanine-arginine-tryptophan (molecular weight, 645 daltons). The amino acid sequence of this peptide represents the biologic active sequence of -melanotropin, which is known to be part of the corticotropin molecule. We utilized melanotropin/corticotropin_6-9. For transdermal administration, the peptide was colloidally adsorbed to an aluminum hydroxide . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?